I
The startup operates a research and development platform focused on synthesizing low molecular weight compounds for new drug candidates. By streamlining the drug development process, the company enables researchers to accelerate timelines and improve the conditions for commercializing new pharmaceuticals.
Updated 3 months ago
Funding
$20.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates a research and development platform focused on synthesizing low molecular weight compounds for new drug candidates. By streamlining the drug development process, the company enables researchers to accelerate timelines and improve the conditions for commercializing new pharmaceuticals.